TotalMarketCap

Aurinia Pharmaceuticals

AUPHNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.171 B

$16.21 -5.29%

Close of 6 Nov 2026

As of 6 Nov 2026, Aurinia Pharmaceuticals (AUPH) has a market capitalization of $2.17B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$283.1M

#2136 by revenue

Earnings

$287.2M

#851 by earnings

Shares outstanding

133,998,660

Latest filing cover page

P/E ratio

7.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #89PERRIGOPRGO$2.18B
  2. #90Vera TherapeuticsVERA$2.17B
  3. #91Aurinia PharmaceuticalsAUPH$2.17B
  4. #92SchrodingerSDGR$2.16B
  5. #93ImmunomeIMNM$2.13B

What if Aurinia Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$210,725.05

Per share 13,004× higher

Bitcoin $1.53T

$11,401.97

Per share 704× higher

Apple $5.02T

$37,431.59

Per share 2,310× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Aurinia Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.